Jennifer M. Wike

Learn More
BACKGROUND Histology is an important factor in the etiology, treatment, and prognosis of cancer. The purpose of this study was to descriptively characterize colorectal cancer (CRC) histology in the United States population. METHODS Data from cancer registries in the National Program of Cancer Registries (NPCR) or Surveillance, Epidemiology and End Results(More)
OBJECTIVE The objective of this study was to report the incidence of primary fallopian tube carcinoma (PFTC) in the United States population and to describe associated demographic and clinical factors. METHODS A total of 3051 PFTC cases diagnosed from 1998 to 2003, reported from population-based cancer registries, were analyzed. Registries contributing(More)
OBJECTIVES The objectives of this study were to determine the adequacy of surgical staging performed on surgically treated epithelial ovarian cancer (EOC) patients with apparent early stage disease and to determine if receipt of surgical staging had an influence on survival. METHODS Detailed surgical staging information was collected from medical records(More)
BACKGROUND The Breast and Prostate Cancer Data Quality and Patterns of Care (POC-BP) Study enabled a reabstraction study of the quality of population-based, central cancer registry data on the characteristics and initial treatment of breast cancer in females and prostate cancer in the United States. METHODS Stratified random samples of 9,103 female breast(More)
BACKGROUND Advances in treatment have improved ovarian cancer survival for most women, although less for the elderly. We report on this disparity and add further evidence about the relationship among age, comorbidity, and survival after ovarian cancer. METHODS To examine age and comorbidity, Centers for Disease Control and Prevention (CDC)-funded cancer(More)
Following the Institute of Medicine's 2009 report on the national priorities for comparative effectiveness research (CER), funding for support of CER became available in 2009 through the American Recovery and Re-investment Act. The Centers for Disease Control and Prevention (CDC) received funding to enhance the infrastructure of population-based cancer(More)
15031 Background: Ovarian cancer (ovca) is the fifth leading cause of cancer death among women in the United States. In 2001, the NPCR program (administered by the Centers for Disease Control and Prevention) initiated a multi-year study to determine the first course of treatment for ovca patients in order to assess whether the ovca standard of care (as(More)
Ovarian cancer is the fifth leading cause of cancer death in the United States, and contrib‐ utes significantly to the worldwide cancer burden [1]. The lack of gynecologic-specific symptoms and effective early detection methods for ovarian cancer leads to a preponder‐ ance of late-stage diagnoses. Ovarian cancer is a surgically-staged and treated disease,(More)
  • 1